trial

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

NCTId NCT07417904
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 30 (estimated)
Sponsored by Howard University
Primary completion 2026-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Sequential
Masking
None
Start
2026-02-16
Primary completion
2026-08
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
BRAVE (Behavioral Response Against Violence Engagement)

Sponsors

Howard UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

1 total
Washington D.C., United States

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2026-08
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
BRAVE (Behavioral Response Against Violence Engagement)
drug
lead_sponsor
Howard University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Early Psychosis
indication
Aggression
indication
Violence Risk
indication